home / stock / pxsly / pxsly quote
Last: | $0.88 |
---|---|
Change Percent: | -7.37% |
Open: | $0.88 |
Close: | $0.88 |
High: | $0.88 |
Low: | $0.88 |
Volume: | 582 |
Last Trade Date Time: | 05/21/2021 04:42:18 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.88 | $0.88 | $0.88 | $0.88 | $0.88 | 582 | 05-21-2021 |
$0.95 | $0.95 | $0.95 | $0.95 | $0.95 | 611 | 05-20-2021 |
$1.47 | $1.47 | $1.47 | $1.47 | $1.47 | 100 | 05-18-2021 |
$0.945 | $0.945 | $0.945 | $0.945 | $0.945 | 280 | 05-12-2021 |
$0.985 | $0.985 | $0.985 | $0.985 | $0.985 | 140 | 05-10-2021 |
$0.995 | $0.995 | $0.995 | $0.995 | $0.995 | 465 | 05-07-2021 |
$0.9083 | $0.9083 | $0.9083 | $0.9083 | $0.9083 | 100 | 05-05-2021 |
$0.93 | $0.93 | $0.93 | $0.93 | $0.93 | 1,400 | 04-29-2021 |
$0.89 | $1.03 | $0.89 | $1.03 | $0.89 | 1,244 | 04-20-2021 |
$0.9966 | $0.9966 | $0.9966 | $0.9966 | $0.9966 | 100 | 04-08-2021 |
$0.95 | $0.95 | $0.95 | $0.95 | $0.95 | 300 | 04-05-2021 |
$1 | $1 | $1 | $1 | $1 | 101 | 03-31-2021 |
$1.02 | $1.02 | $1.02 | $1.02 | $1.02 | 917 | 03-23-2021 |
$0.99 | $0.99 | $0.99 | $0.99 | $0.99 | 990 | 03-22-2021 |
$1.06 | $1.06 | $1.06 | $1.06 | $1.06 | 1,900 | 03-18-2021 |
$1.01 | $1.01 | $1.01 | $1.01 | $1.01 | 2,000 | 03-12-2021 |
$0.965 | $0.965 | $0.965 | $0.965 | $0.965 | 150 | 03-10-2021 |
$0.999 | $0.999 | $0.999 | $0.999 | $0.999 | 3,000 | 03-04-2021 |
$1.01 | $1.01 | $1.01 | $1.01 | $1.01 | 3,000 | 02-26-2021 |
$0.939 | $0.939 | $0.939 | $0.939 | $0.939 | 1,005 | 02-22-2021 |
News, Short Squeeze, Breakout and More Instantly...
Pharmaxis Ltd ADR Company Name:
PXSLY Stock Symbol:
OTCMKTS Market:
Melbourne, Australia (ABN Newswire) - BTC Health Limited (ASX:BTC) is pleased to announce its investee company, BioImpact Pty Ltd, has acquired exclusive distribution rights for specialty respiratory brands Bronchitol(R) and Aridol(R) from Pharmaxis (ASX:PXS) in Australia, New Zealand, Singap...
LONDON , November 15, 2018 /PRNewswire/ -- Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that Pharmaxis Ltd (ASX: PXS), an Australian pharmaceutical research company focused on inflammation and fi...
LONDON , October 11, 2018 /PRNewswire/ -- Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that its Group Business, Pharmaxis Ltd (ASX: PXS), an Australian pharmaceutical research company focused on ...